Cover Image
市場調查報告書

單純皰疹病毒 (HSV) 診斷檢驗的全球市場:醫療設備的開發平台評估

Herpes Simplex Virus (HSV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 361744
出版日期 內容資訊 英文 53 Pages
訂單完成後即時交付
價格
Back to Top
單純皰疹病毒 (HSV) 診斷檢驗的全球市場:醫療設備的開發平台評估 Herpes Simplex Virus (HSV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年07月01日 內容資訊: 英文 53 Pages
簡介

本報告提供全球單純皰疹病毒 (HSV) 診斷檢驗的相關產品的市場上,主要開發中產品與其臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進行階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 的資訊彙整,為您概述為以下內容。 關於其的同時

第1章 目錄

第2章 簡介

  • 單純皰疹病毒 (HSV) 診斷檢驗概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各預估認證時間

第4章 臨床實驗中的開發中產品:各企業

  • HSV診斷檢驗的企業:各臨床實驗階段的開發中產品
  • HSV診斷檢驗:各臨床實驗階段的開發中產品

第5章 單純皰疹病毒 (HSV) 診斷檢驗市場:企業、產品概要

  • Becton, Dickinson and Company
    • 開發中產品及進行中的臨床實驗概要
  • Biokit, S.A.
  • Cepheid
  • Da An Gene Co., Ltd.
  • DiaSorin S.p.A
  • Genera Biosystems Limited
  • Hologic, Inc.
  • OPKO Health, Inc.
  • Qiagen N.V.
  • Roche Diagnostics International Ltd.
  • Theranos, Inc.
  • University of Texas Medical Branch at Galveston
  • VEGA Ltd

第6章 單純皰疹病毒 (HSV) 診斷檢驗市場:目前的趨勢 (共14件)

第7章 附錄

圖表一覽

目錄
Product Code: GDME0208EPD

GlobalData's Medical Devices sector report, "Herpes Simplex Virus (HSV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Herpes Simplex Virus (HSV) Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Herpes Simplex Virus (HSV) Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Herpes Simplex Virus (HSV) Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Herpes Simplex Virus (HSV) Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Herpes Simplex Virus (HSV) Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Herpes Simplex Virus (HSV) Diagnostic Tests Overview

3. Products under Development

  • 3.1. Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Stage of Development
  • 3.2. Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Territory
  • 3.3. Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Regulatory Path
  • 3.4. Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Estimated Approval Date

4. Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products under Development by Companies

  • 4.1. Herpes Simplex Virus (HSV) Diagnostic Tests Companies - Pipeline Products by Stage of Development
  • 4.2. Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Stage of Development

5. Herpes Simplex Virus (HSV) Diagnostic Tests Companies and Product Overview

  • 5.1. Becton, Dickinson and Company Company Overview
    • 5.1.1. Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Biokit, S.A. Company Overview
    • 5.2.1. Biokit, S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Cepheid Company Overview
    • 5.3.1. Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Da An Gene Co., Ltd. Company Overview
    • 5.4.1. Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. DiaSorin S.p.A Company Overview
    • 5.5.1. DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Genera Biosystems Limited Company Overview
    • 5.6.1. Genera Biosystems Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Hologic, Inc. Company Overview
    • 5.7.1. Hologic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. OPKO Health, Inc. Company Overview
    • 5.8.1. OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Qiagen N.V. Company Overview
    • 5.9.1. Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Roche Diagnostics International Ltd. Company Overview
    • 5.10.1. Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Theranos, Inc. Company Overview
    • 5.11.1. Theranos, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. University of Texas Medical Branch at Galveston Company Overview
    • 5.12.1. University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. VEGA Ltd Company Overview
    • 5.13.1. VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview

6. Herpes Simplex Virus (HSV) Diagnostic Tests - Recent Developments

  • 6.1. Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market
  • 6.2. May 16, 2016: Luminex to Highlight ARIES System at the 2016 Clinical Virology Symposium
  • 6.3. May 11, 2016: Theranos Announces Expansion of Board of Directors and New Organizational Structure
  • 6.4. May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results
  • 6.5. Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES HSV 1&2 Assay
  • 6.6. Feb 22, 2016: Luminex Receives Medical Device License for ARIES HSV 1&2 Assay in Canada
  • 6.7. Nov 03, 2015: SeraCare Life Sciences Announces Early Access Programs for ctDNA and RNA Fusion Reference Materials
  • 6.8. Oct 07, 2015: Luminex Corporation Receives FDA Clearance for ARIES HSV 1&2 Assay
  • 6.9. Sep 03, 2015: Focus Diagnostics Receives FDA Clearance to Add Genital Swab Claim to Moderate Complexity Simplexa HSV 1 & 2 Direct Molecular Test
  • 6.10. Jul 29, 2015: SeraCare Life Sciences Unveils Rebranding Initiative to Support Company's Expanding Capabilities for Precision Diagnostics
  • 6.11. Jul 20, 2015: Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene HSV 1
  • 6.12. Jul 20, 2015: Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene HSV 2
  • 6.13. Jul 14, 2015: Luminex Submits FDA 510(k) Submission for ARIES HSV 1&2 Assay
  • 6.14. Jul 02, 2015: FDA Clears Theranos's Herpes Simplex 1 Virus IgG Test

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Stage of Development
  • Table 2: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Territory
  • Table 3: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Regulatory Path
  • Table 4: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Estimated Approval Date
  • Table 5: Herpes Simplex Virus (HSV) Diagnostic Tests Companies - Pipeline Products by Stage of Development
  • Table 6: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Stage of Development
  • Table 7: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: BD Viper LT HSV 1/2 Assay - Product Status
  • Table 9: BD Viper LT HSV 1/2 Assay - Product Description
  • Table 10: Biokit, S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: BIO-FLASH HSV 1+2 IgM Assay - Product Status
  • Table 12: BIO-FLASH HSV 1+2 IgM Assay - Product Description
  • Table 13: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Xpert HSV 1 And 2 Test - Product Status
  • Table 15: Xpert HSV 1 And 2 Test - Product Description
  • Table 16: Xpert HSV CSF Assay - Product Status
  • Table 17: Xpert HSV CSF Assay - Product Description
  • Table 18: Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Real Time PCR Kit - HSV General Type - Product Status
  • Table 20: Real Time PCR Kit - HSV General Type - Product Description
  • Table 21: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Diagnostic Assay - HSV M + cntr - Product Status
  • Table 23: Diagnostic Assay - HSV M + cntr - Product Description
  • Table 24: Genera Biosystems Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Diagnostic Test- Herpes Simplex Virus (HSV) 1 / HSV 2 - Product Status
  • Table 26: Diagnostic Test- Herpes Simplex Virus (HSV) 1 / HSV 2 - Product Description
  • Table 27: Hologic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Panther System - HSV-1 Assay - Product Status
  • Table 29: Panther System - HSV-1 Assay - Product Description
  • Table 30: Panther System - HSV-2 Assay - Product Status
  • Table 31: Panther System - HSV-2 Assay - Product Description
  • Table 32: OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: mChip - Herpes - Product Status
  • Table 34: mChip - Herpes - Product Description
  • Table 35: Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: QIAensemble 400 - Herpes Simplex Virus 1 and 2 - Product Status
  • Table 37: QIAensemble 400 - Herpes Simplex Virus 1 and 2 - Product Description
  • Table 38: Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Cobas 6000 Analyzer Series With c501/e601 HSV-2 Test - Product Status
  • Table 40: Cobas 6000 Analyzer Series With c501/e601 HSV-2 Test - Product Description
  • Table 41: Cobas 6000 Analyzer Series With c501/e601 Module - HSV-1 Test - Product Status
  • Table 42: Cobas 6000 Analyzer Series With c501/e601 Module - HSV-1 Test - Product Description
  • Table 43: Cobas 8000 Analyzer Series With c 701 Module - HSV Type I And II Assay - Product Status
  • Table 44: Cobas 8000 Analyzer Series With c 701 Module - HSV Type I And II Assay - Product Description
  • Table 45: Cobas 8000 Analyzer Series With c 702 Module - HSV Type I and II Assay - Product Status
  • Table 46: Cobas 8000 Analyzer Series With c 702 Module - HSV Type I and II Assay - Product Description
  • Table 47: Theranos, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: HSV-1 IgG Test - Capillary Plasma - Product Status
  • Table 49: HSV-1 IgG Test - Capillary Plasma - Product Description
  • Table 50: HSV-1 IgG Test - Capillary Whole Blood - Product Status
  • Table 51: HSV-1 IgG Test - Capillary Whole Blood - Product Description
  • Table 52: HSV-1 IgG Test - Venous Plasma - Product Status
  • Table 53: HSV-1 IgG Test - Venous Plasma - Product Description
  • Table 54: HSV-1 IgG Test - Venous Serum - Product Status
  • Table 55: HSV-1 IgG Test - Venous Serum - Product Description
  • Table 56: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Diagnostic Assay - HSV - Product Status
  • Table 58: Diagnostic Assay - HSV - Product Description
  • Table 59: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Enzyme Immunoassay - HSV2 - Product Status
  • Table 61: Enzyme Immunoassay - HSV2 - Product Description
  • Table 62: Glossary

List of Figures

  • Figure 1: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Stage of Development
  • Figure 2: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Territory
  • Figure 3: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Regulatory Path
  • Figure 4: Herpes Simplex Virus (HSV) Diagnostic Tests - Pipeline Products by Estimated Approval Date
Back to Top